-
Beam Therapeutics (NASDAQ:BEAM) Receives "Buy" Rating from HC Wainwright
来源: Buzz FX / 01 3月 2025 10:01:13 America/New_York
Beam Therapeutics (NASDAQ:BEAM) Receives "Buy" Rating from HC Wainwright Written by MarketBeat March 1, 2025 Share Link copied to clipboard. Beam Therapeutics ( NASDAQ:BEAM - Get Free Report ) 's stock had its "buy" rating reissued by analy
Read more...